Article
Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment
1 Jun 2020
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of the most common malignancies today. Patients suffer from HCC since its high malignancy and limited treatment means. With the development of genetic research, new therapeutic strategy comes up in the way of gene editing. Clustered regularly interspaced short palindromic repeat/CRISPR-associated nuclease 9 (CRISPR/Cas9) was discovered as an immune sequence in bacteria and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
